What is CVE-2026-31070?

CVE-2026-31070 is a critical-severity vulnerability in N/a, classified under Improper Privilege Management. CVSS score: 9.8/10. Published 2026-05-19.

How severe is CVE-2026-31070?

Critical severity. CVSS v3 base score is 9.8 out of 10.

Privilege escalation in N/a

CVE-2026-31070

The LalanaChami Pharmacy Management System (commit 5c3d028) allows unauthenticated remote attackers to escalate privileges by self-assigning an administrative role during registration. The /api/user/signup endpoint fails to validate the ro…

Vulnerability class: Privilege Escalation

EPSS: 0.001 (29.1th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

N/a — versions n/a

Weakness classification (CWE)

CWE-269 — Improper Privilege Management

References

cve@mitre.org
cve@mitre.org

Frequently asked questions

What is CVE-2026-31070?: CVE-2026-31070 is a critical-severity vulnerability in N/a, classified under Improper Privilege Management. CVSS score: 9.8/10. Published 2026-05-19.
How severe is CVE-2026-31070?: Critical severity. CVSS v3 base score is 9.8 out of 10.